JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Price, J. C.
Right arrow Articles by Mathis, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Price, J. C.
Right arrow Articles by Mathis, C. A.
Journal of Nuclear Medicine Vol. 43 No. 8 1090-1100
© 2002 by Society of Nuclear Medicine


Basic Science Investigations

Sequential H215O PET Studies in Baboons: Before and After Amphetamine

Julie C. Price, PhD1, Wayne C. Drevets, MD2, James Ruszkiewicz, BS1, Phil J. Greer, MS1, Victor L. Villemagne, MD1, Lei Xu, MS3, Sati Mazumdar, PhD3, Michael N. Cantwell, MD1 and Chester A. Mathis, PhD1

1 Department of Radiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
2 Mood and Anxiety Disorders Program, National Institutes of Mental Health, Bethesda, Maryland
3 Department of Biostatistics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

PET and 11C-raclopride have been used to assess dopamine activity in vivo using a paradigm that involved d-amphetamine (AMPH)-induced endogenous dopamine release that led to reductions (relative to baseline) in the 11C-raclopride-specific binding parameter (binding potential). A common assumption in bolus injection PET studies of this type is that cerebral blood flow (CBF) does not vary during the scan. The goal of this work was to examine the effect of AMPH administration on sequential PET measures of CBF. Methods: Eight dynamic H215O PET scans were acquired with arterial blood sampling in 6 baboons: 4 scans before AMPH (over 60 min) and 4 scans after AMPH (over 60 min) (0.6 mg/kg AMPH). Magnetic resonance images (coregistered to PET) were used to define regions of interest that included cortex, striatum (including subregions), and cerebellum. Data were analyzed using a 1-tissue compartment model. CBF was assessed through K1 (mL/mL/min). Results: Temporal patterns of the CBF alterations were similar across regions for each baboon. For 5 of 6 baboons, a general pattern of an initial increase in K1 was observed after AMPH that gradually declined toward baseline, after minimizing anesthesia-induced variability in the in vivo measures. Although these alterations after AMPH were statistically significant in particular subcortical regions and cerebellum, such changes would not likely influence measures of 11C-raclopride binding potential to a significant extent. Conclusion: These data support previous PET studies for which constant blood flow was assumed during the bolus PET 11C-raclopride/AMPH experiment across striatal subregions, while underscoring the importance of considering effects of anesthesia when interpreting in vivo imaging parameters.

Key Words: PET • blood flow • amphetamine




This article has been cited by other articles:


Home page
HypertensionHome page
J. R. Jennings, M. F. Muldoon, J. Price, I. C. Christie, and C. C. Meltzer
Cerebrovascular Support for Cognitive Processing in Hypertensive Patients Is Altered by Blood Pressure Treatment
Hypertension, July 1, 2008; 52(1): 65 - 71.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. R. Jennings, M. F. Muldoon, C. Ryan, J. C. Price, P. Greer, K. Sutton-Tyrrell, F. M. van der Veen, and C. C. Meltzer
Reduced cerebral blood flow response and compensation among patients with untreated hypertension
Neurology, April 26, 2005; 64(8): 1358 - 1365.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. G. Jenkins, R. Sanchez-Pernaute, A.-L. Brownell, Y.-C. I. Chen, and O. Isacson
Mapping Dopamine Function in Primates Using Pharmacologic Magnetic Resonance Imaging
J. Neurosci., October 27, 2004; 24(43): 9553 - 9560.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2002 by the Society of Nuclear Medicine.